With 30 years of ocular research and large pharma drug development experience, iNetX Corporation provides expert guidance on nonclinical ophthalmic DMPK strategies and clinical trial-enabling data generation and evaluation. Consulting services include, but are not limited to:
• DMPK strategies for every stage of compound/device development
• Evaluation of nonclinical data to streamline development effort
• Exploratory and IND-enabling ocular PK and TK study design and execution
• Compose DMPK-related sections for international regulatory submissions
• Ocular therapeutics and technology in-/out-licensing due-diligence
• Feasibility assessment of alternative indications for drugs
• Staff training and establishing in-house ophthalmic development capabilities
Company Details
- Employees
- 3
- Founded
- -
- Address
- San Diego, Ca 92130, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Dry Eye, Glaucoma, AMD, DME, Myopia, Ocular Safety, Nonclinical DMPK, Pharmacokinetics, Small Molecules, Biologics, Biosimilars, Sustained Release Devices, Business Development, International Regulatory Support, Ocular Gene Therapy, Ophthalmic Development, Uveitis, Ophthalmic Development Strategy.
- HQ
- San Diego, CA
Inetx Corporation Questions
Inetx Corporation's LinkedIn profile is https://www.linkedin.com/company/inetx
Inetx Corporation has
3 employees.
View email and phone details for 3
employees at Inetx Corporation.
Inetx Corporation's industry is
Biotechnology Research
Inetx Corporation's top competitors are
100ok Solutions,
Talus Bio,
Atomwise,
Atheln, Inc.,
Iambic Therapeutics,
Zafrens,
Abramson Labor Group.
Inetx Corporation's categories are Biotechnology Research
Inetx Corporation's founding year is 2018
